• Founded: 2016
  • Location: Waltham, MA
  • Employee range: 11 - 50
  • Clinical stage: Clin1
  • Therapy area: Autoimmune & inflammatory diseases
  • Drug types: ONC, IMM
  • Lead product: CUG252 (partner: AbbVie)
  • Product link:

job board

Short description:

Cancer and Inflammation Treatments

Drug notes:

CUG288 Clin0 solid tumors; CUG279 Clin0 solid tumors; CUG105 Clin0 bladder cancer, solid tumors; 4 programs RD solid tumors

Long description:

Cugene is a clinical-stage biotech founded in 2016 and based in Waltham Massachusetts. The team is developing next-generation therapeutics for cancer and autoimmune disease. Their novel molecules for autoimmune disease are designed to target specific cells and promote immune tolerance without causing off-target effects. In addition, their anti-cancer molecules are designed with advanced specificity as well to kill tumor cells without damaging healthy cells. They advertise a collaborative culture where their employees can grow and strive.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy